Search

everythinglearnresearchcommunity

for

Search:↓

Consider Sertoli-Leydig cell tumors in Peutz-Jeghers syndrome patients with adnexal masses.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

Lichen planopilaris in men often affects the scalp, eyebrows, arms, legs, and beard, with many having family members with hair loss.

Improved genetic diagnosis of PCOS can lead to better patient outcomes.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Two new gene mutations cause a rare hair disorder.

Androgenetic alopecia is linked to family history and androgen effects.

Androgenetic alopecia negatively impacts quality of life, especially for women, due to social reactions.

A child used a hair growth lotion for hair loss, but it caused excessive hair growth on his face and neck instead.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The research found specific genes and proteins that affect how fast chickens' feathers grow, which is not solely determined by traditional inheritance patterns.

Androgenic alopecia in men is mainly linked to family history, hormonal imbalances, and metabolic issues, but can also be influenced by lifestyle habits, environmental factors, and deficiencies in certain vitamins and microelements like copper.

The DLQI is a key tool for measuring quality of life in dermatology.

Most low-level light therapy studies did not accurately report how light was measured, affecting treatment reliability.

There is a significant need for better-validated quality of life tools in dermatology.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

rwSALT provides precise hair regrowth measurement from scalp photos.

The method greatly improves low-light sports images' quality and reduces artifacts.

rwSALT accurately measures hair regrowth in alopecia areata using scalp photos.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.

Low-level red light therapy can shorten eye length in some myopic children.

Low-Level Light Therapy improves quality of life more for women than men with hair loss.

The DLQI is reliable but may not fully capture the impact of skin conditions on quality of life, especially in emotional and psychological areas.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

The conclusion is that a new method to measure hair shine was confirmed to match people's visual assessments.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.